Please provide your email address to receive an email when new articles are posted on . The FDA’s Cardiovascular and Renal Drugs Advisory Committee today did not recommend approval of lixivaptan for ...

FDA Approves Astellas Pharma's Vaprisol for the Treatment of Hypervolemic Hyponatremia DEERFIELD, Ill., March 2 -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration ...

As a general rule, the treatment of hyponatremia should be directed at the primary underlying disorder because such treatment might, in itself, correct the electrolyte imbalance. Thiazide diuretics ...

I have a 95 year old nursing home patient (Jessie) with a serum sodium level of 128. What could be causing this and how should it be treated? Most of the water in the body is in the cells. If water ...

The treatment of hyponatremia has largely consisted of identifying and treating the underlying cause, such as correcting volume depletion and eliminating any offending medications. In situations where ...

These agents compete with AVP for the vasopressin type 2-receptor and block the effects of AVP to increase free water absorption. Since these agents lead to increases in free water excretion with ...

VAPRISOL (conivaptan) 20mg/ampule by Astellas Pharma Vaprisol (conivaptan HCl, from Astellas Pharma) Premixed injection, an arginine vasopressin (AVP) receptor antagonist, is available for the ...

Hyponatremia is a condition wherein the concentration of sodium in the blood is low. The normal level of sodium in serum is between 135-145 mEq/L. In hyponatremia, the blood sodium levels fall below ...

Hyponatremia refers to an abnormally low level of the electrolyte sodium (salt) in the blood. Sodium is an electrolyte that helps regulate the amount of water within and around cells in the body.

The FDA has approved an intravenous drug for hospital patients suffering from potentially life-threateningly low sodium levels, the drug's manufacturer said Friday. Astellas Pharma US Inc. said it ...